GRNA
|
$0.2995
-0.03%
-0.07%
0
|
Professional, Scientific, and T...
(0.0% 1d)
(-0.0% 1m)
(-18.9% 1y)
(-0.0% 2d)
(0.4% 3d)
(0.0% 7d)
(-73.35%
volume)
Earnings Calendar:
Market Cap: $ 45,428,554
Sec
Filling
|
Patents
| 2022 employees
greenlight biosciences is a privately-held biotechnology company focused on sustainable production of chemicals and fuels using its patented cell free bioprocessing technology platform. this revolutionary technology enables the biological conversion of economical, renewable substrates to valuable products with unprecedented flexibility and control.
t-cell
renewable
add to watch list
Paper trade
email alert is off